Daniel Chard is Chairman & Chief Executive Officer of Medifast Inc (MED). The company reported total compensation of $5,584,551 for fiscal year 2025.
| Salary | $1,000,000 |
|---|---|
| Bonus | $0 |
| Stock awards | $4,567,664 |
| Option awards | $0 |
| Non-equity incentive plan | $0 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $16,886 |
| Total | $5,584,551 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Medifast Inc filed April 6, 2026, accession 0001628280-26-023890.
| Peer-group chief executive median | $5,565,578 |
|---|---|
| Difference from that median | $18,973 |
| Percentile within the disclosed peer group | 50th |
| Peers with a disclosed figure | 4 |
Medians and percentiles are computed across the peer group Medifast Inc discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Daniel Chard this page | Chairman & Chief Executive Officer | $5,584,551 |
| Anthony Tyree | Former Chief Business Operations Officer | $1,484,720 |
| James Maloney | Chief Financial Officer | $1,428,396 |
| Nicholas Johnson | Chief Field Operations Officer | $1,195,619 |
| Jason Groves | Chief Legal Officer & Corporate Secretary | $1,160,452 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Medifast Inc compensation brief.
Daniel Chard's compensation sits inside Medifast Inc's full executive and board picture — the peer group, pay against peers, incentive design and the board itself.